E2E Competitors

GCV is an FCA Authorised Investment Firm and Venture Builder. We build and back businesses that transform industries and operate a private investor network for experienced investors. We provide investors with access to compelling alternative investments across three core asset classes; Venture Capital, Private Equity and Property. All investment opportunities are carefully selected for their potential to deliver better returns than traditional mainstream investments. Many are SEIS and EIS eligible and offer generous tax reliefs.

AngelNews is a news service for the early-stage investment market focusing on angel investing.

DeBere Capital Partners is a private investment firm focused on high-impact opportunities across life sciences, deep tech, consumer health, and SaaS. We invest directly in the funds and companies we identify, and we represent a portfolio of innovative growth companies, VC and Private Equity funds through strategic partnerships in a placement capacity. We also invest through aligned syndicates, combining corporate finance expertise with strategic capital. Our core interests include breakthrough therapeutics, gene therapy, neurotech, and longevity biotech. In deep tech, we target innovations in Space Technology, AI, neurotechnology, robotics, and next-gen computing. In consumer health, we back brands in fitness, skincare, wellness, and performance. In SaaS, we focus on digital health, telemedicine, and personalized care.